Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Domschke, Katharina
Lawford, Bruce
Young, Ross
Voisey, Joanne
Morris, C. Phillip
Roehrs, Tilmann
Hohoff, Christa
Birosova, Eva
Arolt, Volker
and
Baune, Bernhard T.
2011.
Dysbindin (DTNBP1) – A role in psychotic depression?.
Journal of Psychiatric Research,
Vol. 45,
Issue. 5,
p.
588.
Cheng, Min-Chih
Chuang, Yang-An
Lu, Chao-Lin
Chen, Yu-Jung
Luu, Sy-Ueng
Li, Jun-Ming
Hsu, Shih-Hsin
and
Chen, Chia-Hsiang
2012.
Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 39,
Issue. 1,
p.
149.
Sepulveda, Jorge L.
2012.
Pharmacogenomics in Clinical Therapeutics.
p.
144.
Ayalew, M
Le-Niculescu, H
Levey, D F
Jain, N
Changala, B
Patel, S D
Winiger, E
Breier, A
Shekhar, A
Amdur, R
Koller, D
Nurnberger, J I
Corvin, A
Geyer, M
Tsuang, M T
Salomon, D
Schork, N J
Fanous, A H
O'Donovan, M C
and
Niculescu, A B
2012.
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.
Molecular Psychiatry,
Vol. 17,
Issue. 9,
p.
887.
2012.
Current World Literature.
Current Opinion in Psychiatry,
Vol. 25,
Issue. 2,
p.
155.
Wockner, L F
Noble, E P
Lawford, B R
Young, R McD
Morris, C P
Whitehall, V L J
and
Voisey, J
2014.
Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients.
Translational Psychiatry,
Vol. 4,
Issue. 1,
p.
e339.
Yap, Mei-Yi Alicia
Lo, Yew-Long
Talbot, Konrad
and
Ong, Wei-Yi
2014.
Oxidative stress reduces levels of dysbindin-1A via its PEST domain.
Neurochemistry International,
Vol. 79,
Issue. ,
p.
65.
Glen, W. Bailey
Horowitz, Bryant
Carlson, Gregory C.
Cannon, Tyrone D.
Talbot, Konrad
Jentsch, J. David
and
Lavin, Antonieta
2014.
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.
Hippocampus,
Vol. 24,
Issue. 2,
p.
204.
Bruenig, Dagmar
White, Melanie J.
Young, Ross McD
and
Voisey, Joanne
2014.
Subclinical Psychotic Experiences in Healthy Young Adults: Associations with Stress and Genetic Predisposition.
Genetic Testing and Molecular Biomarkers,
Vol. 18,
Issue. 10,
p.
683.
Xu, Yiliang
Sun, Yuhui
Ye, Haihong
Zhu, Li
Liu, Jianghong
Wu, Xiaofeng
Wang, Le
He, Tingting
Shen, Yan
Wu, Jane Y
and
Xu, Qi
2015.
Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation.
Cell Discovery,
Vol. 1,
Issue. 1,
Tan, Grace Kang Ning
Tee, Shiau Foon
and
Tang, Pek Yee
2015.
Genetic association of single nucleotide polymorphisms in dystrobrevin binding protein 1 gene with schizophrenia in a Malaysian population.
Genetics and Molecular Biology,
Vol. 38,
Issue. 2,
p.
138.
Spiegel, S.
Chiu, A.
James, A. S.
Jentsch, J. D.
and
Karlsgodt, K. H.
2015.
Recognition deficits in mice carrying mutations of genes encoding BLOC‐1 subunits pallidin or dysbindin.
Genes, Brain and Behavior,
Vol. 14,
Issue. 8,
p.
618.
Cheah, S.-Y.
Lawford, B.R.
Young, R.M.
Morris, C.P.
and
Voisey, J.
2015.
Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia.
European Psychiatry,
Vol. 30,
Issue. 4,
p.
486.
Chen, Jingchun
Cao, Fei
Liu, Lanfen
Wang, Lina
and
Chen, Xiangning
2015.
Genetic studies of schizophrenia: an update.
Neuroscience Bulletin,
Vol. 31,
Issue. 1,
p.
87.
Cheah, Sern-Yih
Lurie, Janine K.
Lawford, Bruce R.
Young, Ross McD.
Morris, Charles P.
and
Voisey, Joanne
2016.
Interaction of multiple gene variants and their effects on schizophrenia phenotypes.
Comprehensive Psychiatry,
Vol. 71,
Issue. ,
p.
63.
Lawford, Bruce R.
Barnes, Mark
Morris, C. Phillip
Noble, Ernest P.
Nyst, Phillip
Heslop, Karen
Young, Ross McD.
Voisey, Joanne
and
Connor, Jason P.
2016.
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 61,
Issue. 5,
p.
291.
Schmieg, Nathalie
Rocchi, Cristina
Romeo, Stefania
Maggio, Roberto
Millan, Mark J.
and
Mannoury la Cour, Clotilde
2016.
Dysbindin‐1 modifies signaling and cellular localization of recombinant, human D3 and D2 receptors.
Journal of Neurochemistry,
Vol. 136,
Issue. 5,
p.
1037.
Petit, Emilie I
Michalak, Zuzanna
Cox, Rachel
O’Tuathaigh, Colm M P
Clarke, Niamh
Tighe, Orna
Talbot, Konrad
Blake, Derek
Joel, Josephine
Shaw, Alexander
Sheardown, Steven A
Morrison, Alastair D
Wilson, Stephen
Shapland, Ellen M
Henshall, David C
Kew, James N
Kirby, Brian P
and
Waddington, John L
2017.
Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.
Neuropsychopharmacology,
Vol. 42,
Issue. 6,
p.
1349.
Scheggia, Diego
Mastrogiacomo, Rosa
Mereu, Maddalena
Sannino, Sara
Straub, Richard E.
Armando, Marco
Managò, Francesca
Guadagna, Simone
Piras, Fabrizio
Zhang, Fengyu
Kleinman, Joel E.
Hyde, Thomas M.
Kaalund, Sanne S.
Pontillo, Maria
Orso, Genny
Caltagirone, Carlo
Borrelli, Emiliana
De Luca, Maria A.
Vicari, Stefano
Weinberger, Daniel R.
Spalletta, Gianfranco
and
Papaleo, Francesco
2018.
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.
Nature Communications,
Vol. 9,
Issue. 1,
Chow, Tze Jen
Tee, Shiau Foon
Loh, Siew Yim
Yong, Hoi Sen
Abu Bakar, Abdul Kadir
and
Tang, Pek Yee
2018.
Variants in ZNF804A and DTNBP1 assessed for cognitive impairment in schizophrenia using a multiplex family-based approach.
Psychiatry Research,
Vol. 270,
Issue. ,
p.
1166.
Comments
No Comments have been published for this article.